EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Antiproliferative Mechanisms of Metformin in Breast Cancer: A Systematic Review of the Literature

Aiman Moldasheva, Assem Zhakupova iD, Mohamad Aljofan

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms26010247 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Aiman Moldasheva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Medicine Nazarbayev University, Astana 010000, Kazakhstan. Hauptthemen laut MEDLINE: Metformin, Breast Neoplasms, Cell Proliferation, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nazarbayev University CRP, Nazarbayev University Collaborative Research Project, Social Policy Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin is an antidiabetic drug with reported potential antiproliferative activity against different cancer types including breast cancer. However, the mechanism of action of how metformin can induce its antiproliferative activity is still unclear. Thus, the current study is a systematic review of the literature aiming to explore the reported antiproliferative mechanisms of metformin against breast cancer. The study included seventeen research articles that describe different mechanisms of action against breast cancer. While the majority of the studies confirm the antiproliferative potential of metformin, albeit at different potencies, there appear to be various mechanisms and factors that can influence this effect. There are a number of questions yet to be answered pertaining the use of metformin as an anti-cancer agent, warranting further investigation into this emerging area of research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminBreast NeoplasmsCell ProliferationAntineoplastic AgentsHumansFemaleHypoglycemic AgentsAnimals

Stichwörter der Autor:innen

AMPKbreast cancermTORmetforminsystematic review

Substanzen

MetforminAntineoplastic AgentsHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Biomedical Sciences, School of Medicine Nazarbayev University, Astana 010000, Kazakhstan.
  • Laboratory of Drug Discovery and Development, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.

ORCID-Profile: Assem Zhakupova

Förderung

  • Nazarbayev University CRP
  • Nazarbayev University Collaborative Research Project
  • Social Policy Grant
  • Nazarbayev University School of Medicine

Zitieren

APA

Moldasheva, A., Zhakupova, A., & Aljofan, M. (2024). Antiproliferative Mechanisms of Metformin in Breast Cancer: A Systematic Review of the Literature. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010247

Vancouver

Moldasheva A, Zhakupova A, Aljofan M. Antiproliferative Mechanisms of Metformin in Breast Cancer: A Systematic Review of the Literature. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010247

BibTeX
@article{Moldasheva2024,
  author = {Moldasheva, Aiman and Zhakupova, Assem and Aljofan, Mohamad},
  title = {Antiproliferative Mechanisms of Metformin in Breast Cancer: A Systematic Review of the Literature},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms26010247}
}
Kostenlos starten →